WuXi Biologics CEO: Vaccine CDMO is the next area of growth

Dr Chris Chen launches WuXi Vaccines, announces new facility and a 20-year manufacturing contract worth US$3 billion

picture of

Breaking News

FDA approves TraceLink pilot programmes for workstreams

The two projects aim to improve the supply chain by focusing on traceability and product recalls

Wasdell Group acquires specialist UK manufacturer and packager

Packaging CDMO has acquired Honeywood to expand its pharma and nutraceutical offering

Thermo Fisher acquires Irish API manufacturing site from GSK

Thermo Fisher will pay $100 million to acquire the site but continue to produce APIs for GSK in the upcoming years

The Manufacturing Chemist outsourcing roundtable: part I

Discussing the upcoming and ongoing trends in the contract pharmaceutical sector, Dr Kevin Robinson recently caught up ...

Lonza to manufacture oral somatostatin analogue MYCAPSSA drug candidate in the UK

The Swiss CDMO has signed an advance commercial supply agreement with Chiasma, the US-based biopharma company

Fujifilm Diosynth announces further UK cell culture expansion plans

The construction of the new BioCampus is estimated to cost £12.6m ($16.3m)

The Manufacturing Chemist outsourcing roundtable: part II

Having talked about upcoming trends, potential growth and in-demand services in Part I, I open the second session by ...

Legacy Pharmaceuticals announces long-term lyophilisation strategy

A lyophilisation suite is in the works, with closed RABS filling line technology, 2 to 3 freeze-driers up to 30 sqm ...

FDA allows ADMA intravenous globulin back on the market

This is not the first release of this drug to the US, after initial approval in 2012, it was removed due to ...

CDMO market trends and dynamics

The rise of the embedded model

Broad stripes, bright stars and a thriving pharmaceutical industry: part I

According to one of Stephen Sondheim’s most well-known lyrics, “I like to be in America! OK by me in America!” ...

Cultivating brand advantage for CDMOs

Tackling the perennial challenge of innovation in the pharmaceutical industry

Recipharm introduces end-to-end inhalation platform

Platform offers service from early stage development through commercial manufacturing

Precigen opens cell and gene therapy facility in Maryland

The Intrexon subsidiary facility will scale production to fit clinical trial needs